Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 13

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 13
---
 evolving clients’ needs or requests.

NewGenIvf’s comprehensive
fertility treatment offerings in Thailand, Cambodia, and Kyrgyzstan, primarily including IVF, egg donation (in Cambodia) and surrogacy
services (in Kyrgyzstan), make it convenient for clients in Asia-Pacific market to have access to various fertility services but with
a relatively low cost, as compared with the US market. Meanwhile, the average cost per IVF cycle by NewGenIvf is around US$7,000 (excluding
medication). Each of NewGenIvf’s clinics in Thailand, Cambodia, and Kyrgyzstan has its own specialty, and together, NewGenIvf is
able to provide more flexibility and options to its patients. For example, NewGenIvf’s Thailand clinic focuses on IVF and related
ancillary services including HIV sperm washing, egg freezing, and chromosome screening. The clinic in Cambodia specializes in providing
both IVF services and egg donation services. NewGenIvf opened the clinic in Kyrgyzstan in 2019, which broadened NewGenIvf’s services
by being legally qualified/received approval letter from The Ministry of Health of Kyrgyzstan to offer surrogacy services. As of December
31, 2024, NewGenIvf was the one of the few ARS providers in Kyrgyzstan and one of the few companies in Kyrgyzstan that is licensed to
offer surrogacy services in Kyrgyzstan.

NewGenIvf attributes its track
record of success to its experienced physicians and its ability to provide comprehensive ARS services, allowing it to meet patients’
increasing demand for advanced, high-end, and sophisticated ARS, a higher standard and a wider range of advanced services.

NewGenIvf has extensive experience
serving Asia-Pacific patients and a deep understanding of their general profiles. In particular, NewGenIvf has personnel speaking multiple
languages, including nurses, facilitators, and translators, who are familiar with the health condition and culture of Asia-Pacific patients
from different countries in the region. NewGenIvf believes that it is therefore well-positioned to benefit from market growth driven by
Asia-Pacific patients travelling to its clinics for treatment.

Attractive Market with Significant Demand and Fast Growth

NewGenIvf operates in the
ARS market in Asia Pacific, positioning it to leverage on an attractive market with compelling underlying growth potential.

Built on years of
experience, NewGenIvf has established a strong reputation in its industry